StonvexLoading…
StonvexStonvexStonvexCore line items from UHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.36B | $15.83B | $14.28B | $13.40B |
Operating Income | $1.99B | $1.68B | $1.18B | $1.00B |
Net Income | $1.49B | $1.14B | $717.79M | $675.61M |
EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 |
Total Assets | $15.53B | $14.47B | $13.97B | $13.49B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $137.80M | $125.98M | $119.44M | $102.82M |
Free Cash Flow OCF − CapEx | $849.25M | $1.12B | $524.74M | $262.02M |
Shares Outstanding | 64.46M | 67.90M | 70.13M | 73.83M |